Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as nonalcoholic fatty liver disease (NAFLD), is a spectrum of liver pathology that arises due to accumulation of triglycerides in hepatocytes. Risk factors include diabetes mellitus, insulin resistance, obesity, hypertension, and medications, among others. MASLD ranges from fatty liver or hepatic steatosis but can lead to metabolic dysfunction-associated steatohepatitis (MASH), formerly known as nonalcoholic steatohepatitis (NASH), which features fatty deposits and inflammation. Progressive liver injury and fibrosis can irreversibly develop into cirrhosis and, possibly, primary liver cancer. Patients are usually asymptomatic, but may present with hepatomegaly and right upper quadrant discomfort. Although liver biopsy is the diagnostic gold standard, the diagnosis can also be established by clinical history, imaging, and laboratory tests. The mainstay of management is lifestyle modifications (weight loss and exercise) with control of associated comorbidities.
Last updated: Feb 21, 2025
Fatty liver Liver The liver is the largest gland in the human body. The liver is found in the superior right quadrant of the abdomen and weighs approximately 1.5 kilograms. Its main functions are detoxification, metabolism, nutrient storage (e.g., iron and vitamins), synthesis of coagulation factors, formation of bile, filtration, and storage of blood. Liver: Anatomy (steatotic liver Liver The liver is the largest gland in the human body. The liver is found in the superior right quadrant of the abdomen and weighs approximately 1.5 kilograms. Its main functions are detoxification, metabolism, nutrient storage (e.g., iron and vitamins), synthesis of coagulation factors, formation of bile, filtration, and storage of blood. Liver: Anatomy disease) has alcoholic Alcoholic Persons who have a history of physical or psychological dependence on ethanol. Mallory-Weiss Syndrome (Mallory-Weiss Tear) (alcohol-associated liver Liver The liver is the largest gland in the human body. The liver is found in the superior right quadrant of the abdomen and weighs approximately 1.5 kilograms. Its main functions are detoxification, metabolism, nutrient storage (e.g., iron and vitamins), synthesis of coagulation factors, formation of bile, filtration, and storage of blood. Liver: Anatomy disease) or nonalcoholic (metabolic dysfunction-associated steatotic liver Liver The liver is the largest gland in the human body. The liver is found in the superior right quadrant of the abdomen and weighs approximately 1.5 kilograms. Its main functions are detoxification, metabolism, nutrient storage (e.g., iron and vitamins), synthesis of coagulation factors, formation of bile, filtration, and storage of blood. Liver: Anatomy disease) subtypes.
Metabolic dysfunction-associated steatotic liver Liver The liver is the largest gland in the human body. The liver is found in the superior right quadrant of the abdomen and weighs approximately 1.5 kilograms. Its main functions are detoxification, metabolism, nutrient storage (e.g., iron and vitamins), synthesis of coagulation factors, formation of bile, filtration, and storage of blood. Liver: Anatomy disease (MASLD): previously named Nonalcoholic fatty liver Nonalcoholic fatty liver Fatty liver finding without excessive alcohol consumption. Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) disease (NAFLD):[1,3,5,7,18]
Pathogenesis of NAFLD: Risk factors such as obesity, poor nutrition, type 2 diabetes, insulin resistance, and sedentary lifestyle cause efflux of FFAs from the adipose tissue to the liver. The increased FFAs in hepatic tissue stimulate triglyceride (TG) synthesis and accumulation. This excess of lipids induces an immune response, causing the production of cytokines, reactive oxygen species (ROS), and worsening insulin resistance. Oxidative stress causes lipid peroxidation and tissue damage, amplifying the inflammatory response and leading to the progression of NAFLD.
HCC: hepatocellular carcinoma
NAFL: non-alcoholic fatty liver (now MASLD)
NASH: non-alcoholic steatohepatitis (now MASH)
If progression is not reversed, MASLD can lead to MASH. With further liver Liver The liver is the largest gland in the human body. The liver is found in the superior right quadrant of the abdomen and weighs approximately 1.5 kilograms. Its main functions are detoxification, metabolism, nutrient storage (e.g., iron and vitamins), synthesis of coagulation factors, formation of bile, filtration, and storage of blood. Liver: Anatomy damage, cirrhosis Cirrhosis Cirrhosis is a late stage of hepatic parenchymal necrosis and scarring (fibrosis) most commonly due to hepatitis C infection and alcoholic liver disease. Patients may present with jaundice, ascites, and hepatosplenomegaly. Cirrhosis can also cause complications such as hepatic encephalopathy, portal hypertension, portal vein thrombosis, and hepatorenal syndrome. Cirrhosis and liver Liver The liver is the largest gland in the human body. The liver is found in the superior right quadrant of the abdomen and weighs approximately 1.5 kilograms. Its main functions are detoxification, metabolism, nutrient storage (e.g., iron and vitamins), synthesis of coagulation factors, formation of bile, filtration, and storage of blood. Liver: Anatomy carcinoma (both irreversible) become potential outcomes:
Progression of liver disease due to steatosis:
1. Healthy hepatocytes: no liver damage
2. Bloated hepatocytes with steatosis (distended by fat droplets), no inflammation: nonalcoholic fatty liver/steatosis (still reversible)
3. Inflamed and dying hepatocytes, with possible fibrosis: nonalcoholic steatohepatitis (still reversible)
4. Dead cells: cirrhosis (irreversible liver damage)
5. Cirrhosis can progress to hepatocellular carcinoma (HCC)Image by Lecturio.
Progression of liver disease: steatosis to HCC
Although the pathogenesis of MASLD and its progression to HCC are not completely understood, increased free fatty levels in the liver induce the synthesis of triglycerides, which can result in lipotoxicity. Lipotoxicity induces apoptosis, thereby activating liver macrophages and inflammation through the NF-kB pathway, contributing to the development of HCC. Lipotoxicity also induces the production of reactive oxygen species by causing mitochondrial dysfunction and endoplasmic reticulum stress. This further promotes inflammation, apoptosis and fibrosis, thereby contributing to the development of MASH and MASH-HCC).[14] Deregulation of microRNAs has been associated with different stages of MASLD.[15]
The diagnostic steps for MASLD/MASH may vary depending on testing availability and practice setting. The following information is based primarily on US and UK recommendations for adults. See your local guidelines for additional guidance.
When incidental liver Liver The liver is the largest gland in the human body. The liver is found in the superior right quadrant of the abdomen and weighs approximately 1.5 kilograms. Its main functions are detoxification, metabolism, nutrient storage (e.g., iron and vitamins), synthesis of coagulation factors, formation of bile, filtration, and storage of blood. Liver: Anatomy findings are noted (e.g., ↑ transaminases Transaminases A subclass of enzymes of the transferase class that catalyze the transfer of an amino group from a donor (generally an amino acid) to an acceptor (generally a 2-keto acid). Most of these enzymes are pyridoxyl phosphate proteins. Autoimmune Hepatitis, steatosis Steatosis Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) on imaging or biopsy Biopsy Removal and pathologic examination of specimens from the living body. Ewing Sarcoma), MASLD should be considered if the following are noted during the patient evaluation:
While LFT abnormalities are often found incidentally, other laboratory tests are also important in the assessment of risk factors and to rule out other diagnoses.
Imaging studies cannot be used to make the diagnosis but will often show characteristics of steatosis Steatosis Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD).
(A) Abdominal ultrasonography of a patient with non-alcoholic fatty liver disease showing increased hepatic parenchyma echotexture due to fat infiltration (“brilliant liver”).
(B) After daily administration of Spirulina maxima (a cyanobacterium used as a food supplement), a normal liver parenchymal texture could be observed by ultrasonography.
Patients Patients Individuals participating in the health care system for the purpose of receiving therapeutic, diagnostic, or preventive procedures. Clinician–Patient Relationship with MASLD should undergo risk stratification for fibrosis Fibrosis Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury. Bronchiolitis Obliterans with the fibrosis-4 index (FIB-4), which can help guide the next steps. FIB-4 scoring helps identify patients Patients Individuals participating in the health care system for the purpose of receiving therapeutic, diagnostic, or preventive procedures. Clinician–Patient Relationship with more advanced fibrosis Fibrosis Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury. Bronchiolitis Obliterans. Cutoff values vary depending on the guideline; however, in general terms, it can categorize patients Patients Individuals participating in the health care system for the purpose of receiving therapeutic, diagnostic, or preventive procedures. Clinician–Patient Relationship as:
NAFLD Fibrosis score [19, 20]
A microscopic image of liver tissue affected by non-alcoholic fatty liver disease (NAFLD):
The large and small clear vacuoles represent the cytoplasmic spaces of hepatocytes, which were filled with lipids in vivo. The lipid is removed after fixation but the vacuolated spaces remain.
Portal inflammation is a diagnostic finding in NASH. Histopathologic section was obtained from a patient with steatohepatitis.
Image: “F1” by Gastroenterology Department, Ege University Faculty of Medicine, Izmir, Turkey. License: CC BY 2.0Simplified diagnostic and management algorithm for asymptomatic individuals with incidental liver findings (based on recommendations from the American Association of Clinical Endocrinology and American Gastroenterological Association)
ALT: alanine aminotransferase
AST: aspartate aminotransferase
ELF: enhanced liver fibrosis test
FIB-4 index: fibrosis-4 index
LFTs: liver function tests
LSM: liver stiffness measurement
Follow local institutional protocols, when available. The following information is based on US and UK recommendations. In cases of advanced fibrosis Fibrosis Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury. Bronchiolitis Obliterans, guidance should be sought from a hepatologist.
All patients Patients Individuals participating in the health care system for the purpose of receiving therapeutic, diagnostic, or preventive procedures. Clinician–Patient Relationship with MASLD and MASH should be counseled on weight loss Weight loss Decrease in existing body weight. Bariatric Surgery and physical activity:
Resmetirom:[2,19,20,21]
Management of comorbidities Comorbidities The presence of co-existing or additional diseases with reference to an initial diagnosis or with reference to the index condition that is the subject of study. Comorbidity may affect the ability of affected individuals to function and also their survival; it may be used as a prognostic indicator for length of hospital stay, cost factors, and outcome or survival. St. Louis Encephalitis Virus
Because of the increased risk of cardiovascular morbidity Morbidity The proportion of patients with a particular disease during a given year per given unit of population. Measures of Health Status and mortality Mortality All deaths reported in a given population. Measures of Health Status in patients Patients Individuals participating in the health care system for the purpose of receiving therapeutic, diagnostic, or preventive procedures. Clinician–Patient Relationship with MASLD/MASH, comorbidities Comorbidities The presence of co-existing or additional diseases with reference to an initial diagnosis or with reference to the index condition that is the subject of study. Comorbidity may affect the ability of affected individuals to function and also their survival; it may be used as a prognostic indicator for length of hospital stay, cost factors, and outcome or survival. St. Louis Encephalitis Virus should be aggressively managed.[12]
Dyslipidemia:[7,8,12]
Hypertension Hypertension Hypertension, or high blood pressure, is a common disease that manifests as elevated systemic arterial pressures. Hypertension is most often asymptomatic and is found incidentally as part of a routine physical examination or during triage for an unrelated medical encounter. Hypertension:[7,8]
Diabetes Diabetes Diabetes mellitus (DM) is a metabolic disease characterized by hyperglycemia and dysfunction of the regulation of glucose metabolism by insulin. Type 1 DM is diagnosed mostly in children and young adults as the result of autoimmune destruction of β cells in the pancreas and the resulting lack of insulin. Type 2 DM has a significant association with obesity and is characterized by insulin resistance. Diabetes Mellitus:[7,8,10,12,13,17]
Additionally:[7,8,10,12,13,17]